New registry aims to unlock secrets of pancreatic cancer
NCT ID NCT02775461
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study creates a registry of people with pancreatic diseases or a high risk for pancreatic cancer, such as those with a family history or certain genetic mutations. Researchers will collect medical information and blood samples to study how these conditions develop over time. The goal is to learn more about what causes pancreatic cancer and improve future detection and treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC PANCREATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Icahn School of Medicine at Mount Sinai
RECRUITINGNew York, New York, 10029, United States
-
Mount Sinai West
RECRUITINGNew York, New York, 10019, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood and gut clues may flag pancreatic cancer risk early
- Can a pill rouse the immune system against pancreatic cancer?
- Can a lung drug tame the pain of chronic pancreatitis?
- Can a new ultrasound technique spot hidden pancreatic cancers earlier?
- Can a Decades-Old drug reverse pancreatic scarring?
- A simple breath test might spot multiple cancers before symptoms appear